References
- Rothwell PM. External validity of randomised controlled trials: ‘to whom do the results of this trial apply?’. Lancet 365(9453), 82–93 (2005).
- Bergqvist D, Björck M, Säwe J, Troëng T. Randomized trials or population-based registries. Eur. J. Vasc. Endovasc. Surg. 34(3), 253–256 (2007).
- Persson G, Strömberg J, Svennblad B, Sandblom G. Risk of bleeding associated with use of systemic thromboembolic prophylaxis during laparoscopic cholecystectomy. Br. J. Surg. 99(7), 979–986 (2012).
- Beyer-Westendorf J, Lützner J, Donath L et al. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery. Findings from the ORTHO-TEP registry. Thromb. Haemost. 109(1), 154–163 (2013).
- Milbrink J, Bergqvist D. The incidence of symptomatic venous thromboembolic events in orthopaedic surgery when using routine thromboprophylaxis. VASA 37(4), 353–357 (2008).